| Basics |
Baxter International Inc.
Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$9.49B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.49 | 0.92%
|
| Avg Daily Range (30 D): |
$0.25 | 1.19%
|
| Avg Daily Range (90 D): |
$0.33 | 1.38%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
3.37M |
| Avg Daily Volume (30 D): |
6.67M |
| Avg Daily Volume (90 D): |
6.39M |
| Trade Size |
| Avg Trade Size (Sh.): |
149 |
| Avg Trade Size (Sh.) (30 D): |
108 |
| Avg Trade Size (Sh.) (90 D): |
109 |
| Institutional Trades |
| Total Inst.Trades: |
62,625 |
| Avg Inst. Trade: |
$3.82M |
| Avg Inst. Trade (30 D): |
$4.19M |
| Avg Inst. Trade (90 D): |
$4.59M |
| Avg Inst. Trade Volume: |
.07M |
| Avg Inst. Trades (Per Day): |
11 |
| Market Closing Trades |
| Avg Closing Trade: |
$20.19M |
| Avg Closing Trade (30 D): |
$19.4M |
| Avg Closing Trade (90 D): |
$22.71M |
| Avg Closing Volume: |
372.07K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$-.09
|
$.18
|
|
Diluted EPS
|
|
$-.09
|
$.18
|
|
Revenue
|
$
|
$ 2.84B
|
$ 2.81B
|
|
Gross Profit
|
$
|
$ 950M
|
$ 991M
|
|
Net Income / Loss
|
$
|
$ -46M
|
$ 91M
|
|
Operating Income / Loss
|
$
|
$ 172M
|
$ 191M
|
|
Cost of Revenue
|
$
|
$ 1.89B
|
$ 1.82B
|
|
Net Cash Flow
|
$
|
$ 40M
|
$ -608M
|
|
PE Ratio
|
|
|
|
|
|
|
